Thymus Extract
Requirements/Sources
Therapeutic Dosages
Therapeutic Uses
Safety Issues
References
1 Fiocchi A, Borella E, Riva E, et al. A double-blind clinical trial for the evaluation of the therapeutical effectiveness of a calf thymus derivative (Thymomodulin) in children with recurrent respiratory infections. Thymus. 1986;8:331-339.
2 Garagiola U, Buzzetti M, Cardella E, et al. Immunological patterns during regular intensive training in athletes: quantification and evaluation of a preventive pharmacological approach. J Int Med Res . 1995;23:85-95.
3 Cavagni G, Piscopo E, Rigoli E, et al. Food allergy in children: an attempt to improve the effects of the elimination diet with an immunomodulating agent (thymomodulin). A double-blind clinical trial. Immunopharmacol Immunotoxicol . 1989;11:131-142.
4 Bagnato A, Brovedani P, Comina P, et al. Long-term treatment with thymomodulin reduces airway hyperresponsiveness to methacholine. Ann Allergy . 1989;62:425-428.
5 Civeira MP, Castilla A, Morte S, et al. A pilot study of thymus extract in chronic non-A, non-B hepatitis. Aliment Pharmacol Therap . 1989;3:395-401.
6 Bortolotti F, Cadrobbi P, Crivellaro C, et al. Effect of an orally administered thymic derivative, thymomodulin, in chronic type B hepatitis in children. Curr Ther Res .1988;43:67-72.
7 Galli M, Crocchiolo P, Negri C, et al. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results. Drugs Exp Clin Res . 1985;11:665-669.
8 Raymond RS, Fallon MB, Abrams GA. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial. Ann Intern Med .1998;129:797-800.
9 Skotnicki AB. Therapeutic application of calf thymus extract (TFX). Med Oncol & Tumor Pharmacother .1989;6:31-43.
10 Leung DY, Hirsch RL, Schneider L, et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol . 1990;85:927-933.
11 Beall G, Kruger S, Morales F, et al. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS . 1990;4:679-81.
12 Harper JI, Mason UA, White TR, et al. A double-blind placebo-controlled study of thymostimulin (TP-1) for the treatment of atopic eczema. Br J Dermatol. 1991;125:368-372.
13 Roullet E, Cesaro P, Simon-Lavoine N, et al. Nonathymulin treatment of multiple sclerosis: double-blind pilot study. Acta Neurol Scand . 1989;80:5758.
14 Fransen L, Anthoons J, Hoogewijs G, et al. Thymopentin treatment in genital warts of long duration. Cancer Detect Prev .1988;12:503-509.
15 Malaise M, Franchimont P, Hauwaert C, et al. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis. Surv Immunol Res . 1985;4(Suppl 1):87-93.
16 Bolla K, Djawari D, Kokoschka EM, et al. Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study. Surv Immunol Res . 1985;4(Suppl 1):37-47.
17 Norton S. Raw animal tissues and dietary supplements. N Engl J Med . 2000;343:304-305.
18 Longo F, Lepore L, Agosti E, Panizon F. Evaluation of the effectiveness of thymomodulin in children with recurrent respiratory infections. Pediatr Med Chir 1988;10:603-607.
19 Vettori G, Lazzaro A, Mazzanti P, Cazzola P. Prevention of recurrent respiratory infections in adults. Minerva Med 1987;78:1281-1289.
20 Genova R, Guerra A. A thymus extract (thymomodulin) in the prevention of childhood asthma. Pediatr Med Chir 1983;5:395-402.
21 Marzari R, Mazzanti P, Cazzola P, Pirodda E. Perennial allergic rhinitis: prevention of the acute episodes with Thymomodulin. Minerva Med 1987;78:1675-1681.
22 Fiocchi A, Grasso U, Travaglini P, et al. A double blind clinical trials on the effectiveness of a thymic derivative (Thymomodulin) in the treatment of children with atopic dermatitis. Int J Immunother 1987;3:279-284.
Revision Information
- Reviewer: EBSCO CAM Review Board
- Review Date: 07/2012 -
- Update Date: 07/25/2012 -
Digg
Del.icio.us
Yahoo
Google
Newsvine